Survival benefits of extensive surgery in patients with papillary thyroid microcarcinoma
Copyright © 2023 Elsevier Inc. All rights reserved..
BACKGROUND: Despite the guidelines recommending thyroid lobectomy, many papillary thyroid microcarcinoma (PTMC) patients still undergo total thyroidectomy. PTMC's optimal treatment remains unclear. We aimed to determine whether total thyroidectomy improves outcomes compared to less extensive surgery.
METHODS: We analyzed 6064 PTMC adult patients from the Surveillance, Epidemiology, and End Results (SEER) database (2000-2019) who underwent either total thyroidectomy (n = 3652) or less extensive surgery (n = 2412). Endpoints were overall survival, cancer-specific survival, and recurrence.
RESULTS: Total thyroidectomy patients had a 5.2 % mortality rate versus 8.1 % with less extensive surgery. Recurrence occurred in 1 (0.03 %) total thyroidectomy patient compared to 24 (1.0 %) less extensive surgery patients (HR 0.07, p = 0.01). Median survival was 8.1 years for total thyroidectomy versus 8.8 years for less extensive surgery. Overall survival favored total thyroidectomy (p = 0.001) but cancer-specific survival did not differ.
CONCLUSION: Although total thyroidectomy may not improve cancer-specific survival, it lowers recurrence risk and confers an overall survival advantage for PTMC patients. These findings may help guide surgical decisions.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:229 |
|---|---|
| Enthalten in: |
American journal of surgery - 229(2024) vom: 26. März, Seite 99-105 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Herrera, Marcela [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer databases |
|---|
| Anmerkungen: |
Date Completed 01.03.2024 Date Revised 01.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.amjsurg.2023.11.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364808888 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364808888 | ||
| 003 | DE-627 | ||
| 005 | 20240301232139.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.amjsurg.2023.11.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1313.xml |
| 035 | |a (DE-627)NLM364808888 | ||
| 035 | |a (NLM)37989608 | ||
| 035 | |a (PII)S0002-9610(23)00585-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Herrera, Marcela |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Survival benefits of extensive surgery in patients with papillary thyroid microcarcinoma |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.03.2024 | ||
| 500 | |a Date Revised 01.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: Despite the guidelines recommending thyroid lobectomy, many papillary thyroid microcarcinoma (PTMC) patients still undergo total thyroidectomy. PTMC's optimal treatment remains unclear. We aimed to determine whether total thyroidectomy improves outcomes compared to less extensive surgery | ||
| 520 | |a METHODS: We analyzed 6064 PTMC adult patients from the Surveillance, Epidemiology, and End Results (SEER) database (2000-2019) who underwent either total thyroidectomy (n = 3652) or less extensive surgery (n = 2412). Endpoints were overall survival, cancer-specific survival, and recurrence | ||
| 520 | |a RESULTS: Total thyroidectomy patients had a 5.2 % mortality rate versus 8.1 % with less extensive surgery. Recurrence occurred in 1 (0.03 %) total thyroidectomy patient compared to 24 (1.0 %) less extensive surgery patients (HR 0.07, p = 0.01). Median survival was 8.1 years for total thyroidectomy versus 8.8 years for less extensive surgery. Overall survival favored total thyroidectomy (p = 0.001) but cancer-specific survival did not differ | ||
| 520 | |a CONCLUSION: Although total thyroidectomy may not improve cancer-specific survival, it lowers recurrence risk and confers an overall survival advantage for PTMC patients. These findings may help guide surgical decisions | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cancer databases | |
| 650 | 4 | |a Cancer survival rate | |
| 650 | 4 | |a Patient outcomes | |
| 650 | 4 | |a Surgical procedure | |
| 650 | 4 | |a Thyroid cancer treatment guidelines | |
| 700 | 1 | |a Hussein, Mohammad H |e verfasserin |4 aut | |
| 700 | 1 | |a Persons, Emily |e verfasserin |4 aut | |
| 700 | 1 | |a Alias, Magdy Ramy |e verfasserin |4 aut | |
| 700 | 1 | |a Rabee, Abdelrahman |e verfasserin |4 aut | |
| 700 | 1 | |a Sayed, Abdullah |e verfasserin |4 aut | |
| 700 | 1 | |a Toraih, Eman |e verfasserin |4 aut | |
| 700 | 1 | |a Kandil, Emad |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of surgery |d 1945 |g 229(2024) vom: 26. März, Seite 99-105 |w (DE-627)NLM000025658 |x 1879-1883 |7 nnns |
| 773 | 1 | 8 | |g volume:229 |g year:2024 |g day:26 |g month:03 |g pages:99-105 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.amjsurg.2023.11.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 229 |j 2024 |b 26 |c 03 |h 99-105 | ||